Changes in smoking status affect women more than men: results of the Lung Health Study - PubMed (original) (raw)
Clinical Trial
. 2003 Jun 1;157(11):973-9.
doi: 10.1093/aje/kwg083.
Affiliations
- PMID: 12777360
- DOI: 10.1093/aje/kwg083
Clinical Trial
Changes in smoking status affect women more than men: results of the Lung Health Study
John E Connett et al. Am J Epidemiol. 2003.
Abstract
Lung Health Study participants were smokers aged 35-60 years with mild lung function impairment who participated in a 5-year, 10-center (nine in the United States, one in Canada) clinical trial in 1986-1994. The authors compared the relation of randomized treatment assignments and of smoking history during the study with changes in lung function between men and women. Spirometry was performed annually, and 3,348 men and 1,998 women attended the follow-up clinic visit that included spirometry at year 5. This paper reports on an analysis of changes in lung function by gender, treatment group, and three smoking history categories: sustained quitters, intermittent quitters, and continuing smokers. Among participants who quit smoking in the first year, mean forced expiratory volume in 1 second (FEV(1)) expressed as a percentage of the predicted value of FEV(1 )given the person's age, height, gender, and race (FEV(1)%) increased more in women (3.7% of predicted) than in men (1.6% of predicted) (p < 0.001). Across the 5-year follow-up period, among sustained quitters, women gained more in FEV(1)% of predicted than did men. Methacholine reactivity was more strongly related to rates of decline in women than in men (p < 0.001). Therefore, among persons at risk for chronic obstructive pulmonary disease, smoking cessation has an even clearer advantage for women than it does for men.
Similar articles
- The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.
Wise RA, Kanner RE, Lindgren P, Connett JE, Altose MD, Enright PL, Tashkin DP; Lung Health Study Research Group. Wise RA, et al. Chest. 2003 Aug;124(2):449-58. doi: 10.1378/chest.124.2.449. Chest. 2003. PMID: 12907528 Clinical Trial. - Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, Tashkin DP; Lung Health Study Research Group. Scanlon PD, et al. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90. doi: 10.1164/ajrccm.161.2.9901044. Am J Respir Crit Care Med. 2000. PMID: 10673175 Clinical Trial. - Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study.
Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, O'Hara P, Owens GR, Rand CS, Tashkin DP. Wise RA, et al. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):866-72. doi: 10.1164/ajrccm.157.3.9706076. Am J Respir Crit Care Med. 1998. PMID: 9517604 Clinical Trial. - Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Anthonisen NR, et al. JAMA. 1994 Nov 16;272(19):1497-505. JAMA. 1994. PMID: 7966841 Clinical Trial. - Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
Cole JM, Sheehan AH, Jordan JK. Cole JM, et al. Ann Pharmacother. 2012 Dec;46(12):1717-21. doi: 10.1345/aph.1R283. Epub 2012 Nov 20. Ann Pharmacother. 2012. PMID: 23170031 Review.
Cited by
- Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France.
Guénégou A, Leynaert B, Bénessiano J, Pin I, Demoly P, Neukirch F, Boczkowski J, Aubier M. Guénégou A, et al. J Med Genet. 2006 Aug;43(8):e43. doi: 10.1136/jmg.2005.039743. J Med Genet. 2006. PMID: 16882737 Free PMC article. - Gender specific differences in the pros and cons of smoking among current smokers in Eastern Kentucky: implications for future smoking cessation interventions.
Hazen DA, Mannino DM, Clayton R. Hazen DA, et al. Int J Environ Res Public Health. 2008 Dec;5(4):230-42. doi: 10.3390/ijerph5040230. Int J Environ Res Public Health. 2008. PMID: 19190354 Free PMC article. - Sex differences and sex steroids in lung health and disease.
Townsend EA, Miller VM, Prakash YS. Townsend EA, et al. Endocr Rev. 2012 Feb;33(1):1-47. doi: 10.1210/er.2010-0031. Epub 2012 Jan 12. Endocr Rev. 2012. PMID: 22240244 Free PMC article. Review. - Prediction of COPD risk accounting for time-varying smoking exposures.
Chang JT, Meza R, Levy DT, Arenberg D, Jeon J. Chang JT, et al. PLoS One. 2021 Mar 10;16(3):e0248535. doi: 10.1371/journal.pone.0248535. eCollection 2021. PLoS One. 2021. PMID: 33690706 Free PMC article. Clinical Trial. - Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on antiretroviral therapy.
Yadav A, Gionet G, Karaj A, Kossenkov AV, Kannan T, Putt ME, Stephens Shields AJ, Ashare RL, Collman RG. Yadav A, et al. AIDS. 2024 Dec 1;38(15):2010-2020. doi: 10.1097/QAD.0000000000004015. Epub 2024 Sep 13. AIDS. 2024. PMID: 39283742
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical